Dublin, Sept. 26, 2025 (GLOBE NEWSWIRE) -- The "Anemia Treatment Market Report by Disease Type, Therapy Class, Route of Administration, Countries and Company Analysis, 2025-2033" report has been added ...

November 29, 2006 (San Diego) — A late-breaking session was quickly organized at the American Society of Nephrology Renal Week 2006 to allow the principal investigators of the just-published ...

A new discovery about how the body makes red blood cells could lead to improved treatments for anemia. Share on Pinterest A new discovery about red blood cells may lead to new treatments for anemia.

Inflammatory bowel disease (IBD) is commonly associated with iron deficiency anemia (IDA), with a multifactorial pathophysiology. Diagnosis of both IDA and IBD places patients at risk for poor quality ...

In the prospective CKD-DOPPS study, only 40% for patients with hemoglobin less than 10 g/dL initiated anemia medication. Only a subset of patients with nondialysis-dependent chronic kidney disease ...

In the CREDENCE trial, patients receiving canagliflozin had reduced risks of initiating iron therapy and erythropoiesis-stimulating agents compared with patients receiving placebo. In addition to its ...

Comorbidities and advanced CKD were prevalent among the approximately 275,000 patients with anemia of CKD from the international DISCOVER CKD cohort. Patients with anemia of chronic kidney disease ...

The US FDA has approved the drug Mitapivat, marketed as Aqvesme, as the very first oral therapy for anemia in adults with ...

Anemia remains a major cause of mortality and morbidity in developing countries where resources to determine the underlying etiology remain poor. There are three basic mechanisms for developing anemia ...

Delivers rapid, durable responses in wAIHA, the more common form of this potentially life-threatening disease — HONG KONG and SHANGHAI and ...